.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Boehringer Ingelheim
Express Scripts
Argus Health
QuintilesIMS
Accenture
US Army
Harvard Business School
AstraZeneca
Johnson and Johnson
Medtronic

Generated: September 22, 2017

DrugPatentWatch Database Preview

STADOL Drug Profile

« Back to Dashboard

Which patents cover Stadol, and what generic Stadol alternatives are available?

Stadol is a drug marketed by Apothecon and Bristol Myers Squibb and is included in two NDAs.

The generic ingredient in STADOL is butorphanol tartrate. There are seven drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the butorphanol tartrate profile page.

Summary for Tradename: STADOL

Patents:0
Applicants:2
NDAs:2
Bulk Api Vendors: see list19
Patent Applications: see list4,458
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:STADOL at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Apothecon
STADOL
butorphanol tartrate
INJECTABLE;INJECTION017857-004Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Apothecon
STADOL PRESERVATIVE FREE
butorphanol tartrate
INJECTABLE;INJECTION017857-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Bristol Myers Squibb
STADOL
butorphanol tartrate
SPRAY, METERED;NASAL019890-001Dec 12, 1991DISCNNoNo► Subscribe► Subscribe► Subscribe
Apothecon
STADOL PRESERVATIVE FREE
butorphanol tartrate
INJECTABLE;INJECTION017857-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: STADOL

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Bristol Myers Squibb
STADOL
butorphanol tartrate
SPRAY, METERED;NASAL019890-001Dec 12, 1991► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Cerilliant
Citi
AstraZeneca
Deloitte
Medtronic
Fuji
Chubb
Cipla
Johnson and Johnson
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot